Research Week 2020
The FDA drug development process consists of various phases and determines whether a new treatment for a specific condition is safe and effective for its intended use. Learn more this week!
Research Week 2020 is July 20-24, which is an opportunity for you to take a look behind the science of lupus research.
Without clinical trials, we would not be able to develop new therapies, improve patient outcomes, and advance the quality of care.
This week you’ll learn more about clinical trials and how they work, get an inside look at research at different phases of its progress, meet several of the researchers we support who are solving the most complex and challenging mysteries in lupus, and hear directly from a person with lupus why trials are so imperative for the lupus community.
Since 1977 the Lupus Foundation of America has supported every major lupus research breakthrough. These accomplishments would not have been possible without the generous support of people like you!
What we’re doing to advance new treatments
Developing new treatments for lupus is incredibly complex. There are many challenges researchers face along the way, from how a trial is designed to how to measure improvements.
Here’s a few ways we are addressing these challenges head on:
Combined clinical trial results from multiple studies into a single database to identify trends and gain insights so new treatments can get to the people who need them faster.
Designed new lupus disease activity measurement tools that integrate patients' concerns and priorities as well as the clinician's. It's the first tool to evaluate treatment decisions and the effectiveness of treatments.
Provided 3,000 clinical investigators in more than 50 countries with standardized training on the correct use of the instruments that measure disease activity in clinical trials to obtain more consistent, accurate data.
Presented consensus recommendations to the U.S. Food and Drug Administration (FDA) for improving lupus clinical trial design, allowing for smaller, more efficient trials.